LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,000 | +42.9% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $7,000 | -30.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $10,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $10,000 | -9.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $11,000 | -91.6% | 100 | -89.6% | 0.00% | -96.3% |
| Q4 2018 | $131,000 | +47.2% | 962 | +196.0% | 0.03% | -34.1% |
| Q3 2018 | $89,000 | +23.6% | 325 | -35.0% | 0.04% | +105.0% |
| Q3 2017 | $72,000 | -99.9% | 500 | 0.0% | 0.02% | +33.3% |
| Q2 2017 | $61,000,000 | +8.9% | 500 | 0.0% | 0.02% | -6.2% |
| Q1 2017 | $56,000,000 | +9.8% | 500 | 0.0% | 0.02% | +77.8% |
| Q4 2016 | $51,000,000 | +99900.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $51,000 | -13.6% | 500 | 0.0% | 0.01% | -52.6% |
| Q2 2016 | $59,000 | +11.3% | 500 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $53,000 | -1.9% | 500 | 0.0% | 0.02% | -5.0% |
| Q4 2015 | $54,000 | – | 500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |